<drug type="small molecule" created="2015-12-03" updated="2017-03-15">
  <drugbank-id primary="true">DB11228</drugbank-id>
  <name>Methyl cellulose</name>
  <description>Methyl cellulose is a stabiliser, thickener and emulsifier for foodstuffs Different kinds of methyl cellulose can be prepared depending on the number of hydroxyl groups substituted. Cellulose is a polymer consisting of numerous linked glucose molecules, each of which exposes three hydroxyl groups. The Degree of Substitution (DS) of a given form of methyl cellulose is defined as the average number of substituted hydroxyl groups per glucose. The theoretical maximum is thus a DS of 3.0, however more typical values are 1.3 2.6. Methyl cellulose (or methylcellulose) is a chemical compound derived from cellulose. It is a hydrophilic white powder in pure form and dissolves in cold (but not in hot) water, forming a clear viscous solution or gel. It is sold under a variety of trade names and is used as a thickener and emulsifier in various food and cosmetic products, and also as a treatment of constipation. Like cellulose, it is not digestible, not toxic, and not allergenic. Methyl cellulose belongs to the family of Dihexoses. These are disaccharides containing two hexose carbohydrates.</description>
  <cas-number>9004-67-5</cas-number>
  <unii>P0NTE48364</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <title>HMDB</title>
        <url>http://www.hmdb.ca/metabolites/HMDB29925</url>
      </link>
      <link>
        <title>Wikipedia</title>
        <url>https://en.wikipedia.org/wiki/Methyl_cellulose</url>
      </link>
      <link>
        <title>FDA</title>
        <url>https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260473.htm</url>
      </link>
      <link>
        <title>Toxnet</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1198</url>
      </link>
      <link>
        <title>ChemIDplus</title>
        <url>https://chem.nlm.nih.gov/chemidplus/rn/9004-67-5</url>
      </link>
      <link>
        <title>Webmd</title>
        <url>http://www.webmd.com/drugs/2/drug-6391/methylcellulose-laxative-oral/details</url>
      </link>
    </links>
  </general-references>
  <synthesis-reference/>
  <indication>Clinical:&#13;
Artificial tears and saliva: Solutions containing methyl cellulose or similar cellulose derivatives are used as substitute for tears or saliva if the natural production of these fluids is disturbed.&#13;
&#13;
Nutritional supplement capsules : Methyl cellulose is used in the manufacture of capsules in nutritional supplements, its edible and nontoxic properties provide a vegetarian alternative to the use of gelatin.&#13;
&#13;
Treatment of constipation : When eaten, methyl cellulose is not absorbed by the intestines but passes through the digestive tract undisturbed. It attracts large amounts of water into the colon, producing a softer and bulkier stool. It is used to treat constipation, diverticulosis, hemorrhoids and irritable bowel syndrome. It should be taken with sufficient amounts of fluid to prevent dehydration.&#13;
&#13;
Cell culture/virology : &#13;
Methyl cellulose is also used in cell culture to study viral replication. It is dissolved in the same nutrient-containing medium in which cells are normally grown. A single layer of cells are grown on a flat surface, then infected with a virus for a short time. The strength of the viral sample used will determine how many cells get infected during this time. The thick methyl cellulose medium is then added on top of the cells in place of normal liquid medium. As the viruses replicate in the infected cells, they are able to spread between cells whose membrances touch each other, but are trapped when they enter the methyl cellulose. Only cells closely neighboring an infected cell will become infected and die. This leaves small regions of dead cells called plaques in a larger background of living uninfected cells. The number of plaques formed is determined by the strength of the original sample.&#13;
&#13;
Bacterial and Protozoal motility inhibitor: Aqueous methyl cellulose solutions have been used to slow bacterial and protozoal cell motility for closer inspection. Changing the amount of methyl cellulose in solution permits the adjustment of the solution's viscosity.&#13;
&#13;
Stem cell differentiation : Methyl cellulose is used in the most common approaches to quantify multiple or single lineage-committed hematopoietic progenitors, called colony-forming cells (CFCs) or colony-forming units (CFUs), in combination with culture supplements that promote their proliferation and differentiation, and allow the clonal progeny of a single progenitor cell to stay together and thus form a colony of more mature cells.</indication>
  <pharmacodynamics>It increases the bulk in your stool, an effect that helps to cause movement of the intestines. It also works by increasing the amount of water in the stool, making the stool softer and easier to pass.</pharmacodynamics>
  <mechanism-of-action>Methylcellulose absorbs water in the gastrointestinal lumen thereby increasing  the bulk of the stool. This leads to distension and stimulation of peristalsis. The ability of methylcellulose to absorb water may contribute to its efficacy in the management of diarrhea by once again increasing the bulk and consistency of the stool.</mechanism-of-action>
  <toxicity>Organism: Mouse&#13;
Test type: LD50&#13;
Route : Intraperitoneal&#13;
Reported Dose: 275gm/kg ( 275000mg/kg)&#13;
Toxic Effect: Details of toxic effects not reported other than lethal dose value&#13;
&#13;
Organism: Mouse&#13;
Test type: LDLo&#13;
Route : Intravenous&#13;
Reported Dose: 1gm/kg ( 1000mg/kg)&#13;
Toxic Effect: Details of toxic effects not reported other than lethal dose value&#13;
</toxicity>
  <metabolism>Reported that when methylcellulose was given iv to dog and rabbit ,  aside from effect upon circulating blood, inability of body to degrade substance led to its retention &amp; accumulation in liver, spleen, lymph nodes, kidney, and vascular walls.</metabolism>
  <absorption> Cellulose derivatives considered in this report are virtually unabsorbed and little or no degradation of absorbed and little or no degradation of absorbable products occurs in the human digestive tract. In humans, virtually 100 percent of orally ingested methyl cellulose can be recovered in the feces withihn four days, indicating that absorption does not occur.</absorption>
  <half-life>4.2 minutes</half-life>
  <protein-binding/>
  <route-of-elimination>When swallowed they are not absorbed to any appreciable degree and appear unchanged in feces.</route-of-elimination>
  <volume-of-distribution>accumulation in liver, spleen, lymph nodes, kidney, and vascular walls.</volume-of-distribution>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds.</description>
    <direct-parent>Oligosaccharides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic oxygen compounds</superclass>
    <class>Organooxygen compounds</class>
    <subclass>Carbohydrates and carbohydrate conjugates</subclass>
    <alternative-parent>Acetals</alternative-parent>
    <alternative-parent>Dialkyl ethers</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>O-glycosyl compounds</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <alternative-parent>Oxanes</alternative-parent>
    <substituent>Acetal</substituent>
    <substituent>Aliphatic heteromonocyclic compound</substituent>
    <substituent>Dialkyl ether</substituent>
    <substituent>Ether</substituent>
    <substituent>Glycosyl compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>O-glycosyl compound</substituent>
    <substituent>Oligosaccharide</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Oxacycle</substituent>
    <substituent>Oxane</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001903</drugbank-id>
      <name>Methylcellulose (100 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001902</drugbank-id>
      <name>Methylcellulose (15 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001901</drugbank-id>
      <name>Methylcellulose (1500 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001900</drugbank-id>
      <name>Methylcellulose (25 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001899</drugbank-id>
      <name>Methylcellulose (400 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001559</drugbank-id>
      <name>Methylcellulose (4000 MPa.s)</name>
      <unii/>
      <cas-number>9004-67-5</cas-number>
      <inchikey/>
    </salt>
  </salts>
  <synonyms>
    <synonym language="" coder="">Cellulose methyl</synonym>
    <synonym language="" coder="">cellulose methyl ether</synonym>
    <synonym language="" coder="">Cellulose methylate</synonym>
    <synonym language="" coder="">methylated cellulose</synonym>
    <synonym language="" coder="">Methylcellulose</synonym>
    <synonym language="Latin" coder="">Methylcellulosum</synonym>
    <synonym language="Spanish" coder="">Metilcelulosa</synonym>
  </synonyms>
  <products>
    <product>
      <name>Citrucel</name>
      <labeller>Glaxo Smith Kline Consumer Healthcare Holdings (Us) Llc</labeller>
      <ndc-id/>
      <ndc-product-code>0135-0089</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-09-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>2 g/19g</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Citrucel</name>
      <labeller>Glaxo Smith Kline Consumer Healthcare Holdings (Us) Llc</labeller>
      <ndc-id/>
      <ndc-product-code>0135-0090</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-09-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>2 g/10.2g</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Citrucel</name>
      <labeller>Glaxo Smith Kline Consumer Healthcare Holdings (Us) Llc</labeller>
      <ndc-id/>
      <ndc-product-code>0135-0199</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>500 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cvs Health Soluble Fiber Therapy</name>
      <labeller>Cvs Health</labeller>
      <ndc-id/>
      <ndc-product-code>59779-896</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>2 g/10.2g</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Entrocel Solution 1.8%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00750700</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>1.8 %</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Fiber Therapy</name>
      <labeller>Major</labeller>
      <ndc-id/>
      <ndc-product-code>0904-5675</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2008-04-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>2 g/19g</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gnp Fiber Therapy</name>
      <labeller>Amerisource Bergen</labeller>
      <ndc-id/>
      <ndc-product-code>24385-466</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-09-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>500 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Health Mart Fiber Caplets</name>
      <labeller>Mc Kesson</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0134</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>500 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Methylax</name>
      <labeller>Seaford Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248253</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>2 g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Murocel Liq 1%</name>
      <labeller>Bausch &amp; Lomb Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00750808</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-05</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength>1 %</strength>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Prodiem Bulk Fibre Therapy Powder</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248225</dpd-id>
      <started-marketing-on>2003-12-03</started-marketing-on>
      <ended-marketing-on>2007-07-18</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength>2 g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Prodiem Bulk Fibre Therapy Powder Sugar Free</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248226</dpd-id>
      <started-marketing-on>2003-12-03</started-marketing-on>
      <ended-marketing-on>2007-07-18</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength>2 g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Restorafibre Caplet</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02461137</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>500 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Restorafibre Powder Sugar Free</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02461145</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>2 g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Slim-mint Gum</name>
      <labeller>Stella Pharmaceutical Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00442976</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Gum, chewing</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sunmark Fiber Laxative</name>
      <labeller>Mc Kesson</labeller>
      <ndc-id/>
      <ndc-product-code>49348-541</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>500 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part334</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Sunmark Fiber Laxative</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Health Mart Fiber Caplets</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Slim-mint Gum</name>
      <ingredients>Methyl cellulose + Benzocaine</ingredients>
    </mixture>
    <mixture>
      <name>Prodiem Bulk Fibre Therapy Powder</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Prodiem Bulk Fibre Therapy Powder Sugar Free</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Murocel Liq 1%</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Entrocel Solution 1.8%</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Methylax</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Gnp Fiber Therapy</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Fiber Therapy</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Cvs Health Soluble Fiber Therapy</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Citrucel</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Citrucel</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Citrucel</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Restorafibre Caplet</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
    <mixture>
      <name>Restorafibre Powder Sugar Free</name>
      <ingredients>Methyl cellulose</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Biomedical and Dental Materials</category>
      <mesh-id>D001697</mesh-id>
    </category>
    <category>
      <category>Biopolymers</category>
      <mesh-id>D001704</mesh-id>
    </category>
    <category>
      <category>Bulk-Forming Laxatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Cellulose</category>
      <mesh-id>D002482</mesh-id>
    </category>
    <category>
      <category>Chemical Actions and Uses</category>
      <mesh-id>D020164</mesh-id>
    </category>
    <category>
      <category>Drugs for Constipation</category>
      <mesh-id/>
    </category>
    <category>
      <category>Glucans</category>
      <mesh-id>D005936</mesh-id>
    </category>
    <category>
      <category>Macromolecular Substances</category>
      <mesh-id>D046911</mesh-id>
    </category>
    <category>
      <category>Manufactured Materials</category>
      <mesh-id>D008420</mesh-id>
    </category>
    <category>
      <category>Polymers</category>
      <mesh-id>D011108</mesh-id>
    </category>
    <category>
      <category>Polysaccharides</category>
      <mesh-id>D011134</mesh-id>
    </category>
    <category>
      <category>Specialty Uses of Chemicals</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Technology, Industry, and Agriculture</category>
      <mesh-id>D013676</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength>2 g/10.2g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>1.8 %</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength>2 g/19g</strength>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Ophthalmic</route>
      <strength>1 %</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength>2 g</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>500 mg</strength>
    </dosage>
    <dosage>
      <form>Gum, chewing</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>500 mg/1</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A06AC06">
      <level code="A06AC">Bulk-forming laxatives</level>
      <level code="A06A">DRUGS FOR CONSTIPATION</level>
      <level code="A06">DRUGS FOR CONSTIPATION</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>0.44</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.20e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>COC[C@H]1O[C@@H](O[C@@H]2[C@@H](COC)O[C@@H](O[C@@H]3[C@@H](COC)O[C@@H](OC)[C@H](OC)[C@H]3OC)[C@H](OC)[C@H]2OC)[C@H](OC)[C@@H](OC)[C@@H]1OC</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>(C9H16O5)nC20H38O11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C29H54O16/c1-30-12-15-18(33-4)21(34-5)25(38-9)28(42-15)45-20-17(14-32-3)43-29(26(39-10)23(20)36-7)44-19-16(13-31-2)41-27(40-11)24(37-8)22(19)35-6/h15-29H,12-14H2,1-11H3/t15-,16-,17-,18-,19-,20-,21+,22+,23+,24-,25-,26-,27-,28+,29+/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>LNAZSHAWQACDHT-XIYTZBAFSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>10120</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>53448</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D04996</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Methyl_cellulose</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
